Alpha Tau Medical Announcements for Upcoming Investor Conferences
Alpha Tau Medical Announces Participation in Key Investor Conferences
Alpha Tau Medical Ltd. (NASDAQ: DRTS, DRTSW), a pioneering company in innovative alpha-radiation cancer therapy, is set to take part in several important investor conferences. This engagement highlights its commitment to communicating advancements in cancer treatment technology, particularly focusing on its proprietary treatment method, Alpha DaRT.
Upcoming Conference Presentations
During these conferences, Alpha Tau's CFO Raphi Levy will deliver a corporate overview and provide updates on the latest developments related to the Alpha DaRT therapy. These presentations are great opportunities for investors and stakeholders to understand the progress that Alpha Tau has made in the fields of oncology and medical innovation.
H.C. Wainwright 26th Annual Global Investment Conference
Alpha Tau Medical will present at the H.C. Wainwright Annual Global Investment Conference, scheduled for September 10th, where Raphi Levy will provide insights into the company's strategic direction and upcoming initiatives. Interested attendees are encouraged to tune in for this informative session.
Sidoti Small-Cap Virtual Investor Conference
Following that, the company is also participating in the Sidoti Small-Cap Virtual Investor Conference taking place on September 18-19. This platform is designed to foster dialogue between small-cap companies and potential investors, with Levy presenting an update aimed at highlighting the unique aspects of Alpha Tau’s technology.
Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference
Alpha Tau Medical will also be involved in the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference on September 26th. This specialized conference allows the company to engage with industry-specific investors interested in the pharmacological and therapeutic advancements driven by cutting-edge research.
Lytham Partners Fall 2024 Investor Conference
Concluding the series of presentations, Alpha Tau will appear at the Lytham Partners Fall 2024 Investor Conference on October 1st, providing a further platform for engagement and showcasing its continuing advancements in cancer therapies.
About Alpha Tau Medical Ltd.
Founded in 2016, Alpha Tau is an oncology therapeutics company with headquarters in Israel, dedicated to the research, development, and commercialization of its innovative cancer treatment technology, Alpha DaRT. This pioneering method targets solid tumors, utilizing alpha radiation to maximize therapeutic effects while seeking to minimize damage to surrounding healthy tissue.
About Alpha DaRT
Alpha DaRT, or Diffusing Alpha-emitters Radiation Therapy, employs intratumoral delivery of radium-224 to achieve precise and powerful alpha-irradiation. As the radium decays, it releases short-lived daughter isotopes that produce high-energy alpha particles effective at destroying tumor cells. Specifically designed for solid tumors, Alpha DaRT provides a focused approach to treatment that aims to spare adjacent healthy tissues.
Investor Relations Contact
For inquiries, please reach out to the investor relations team via email: IR@alphatau.com.
Frequently Asked Questions
What is Alpha DaRT therapy?
Alpha DaRT is an innovative cancer therapy that uses alpha radiation to target and destroy solid tumors while minimizing damage to surrounding healthy tissue.
Who will present for Alpha Tau at the conferences?
CFO Raphi Levy will present on behalf of Alpha Tau Medical at each of the upcoming investor conferences.
When is the H.C. Wainwright Conference?
The H.C. Wainwright 26th Annual Global Investment Conference is scheduled for September 10th.
How can investors learn more about Alpha Tau's progress?
Investors can attend the company's presentations at the scheduled conferences or contact the investor relations team for more detailed information.
What is the significance of the conferences for Alpha Tau?
These conferences provide a vital opportunity for Alpha Tau Medical to engage with investors, showcase advancements, and discuss strategic initiatives regarding its treatments.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.